| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intra-Abdominal Fat | 57 | 2017 | 624 | 10.920 |
Why?
|
| Subcutaneous Fat | 30 | 2016 | 401 | 5.700 |
Why?
|
| Albuminuria | 33 | 2017 | 659 | 4.790 |
Why?
|
| Adiposity | 43 | 2018 | 1891 | 4.680 |
Why?
|
| Cardiovascular Diseases | 118 | 2018 | 15645 | 4.150 |
Why?
|
| Body Fat Distribution | 18 | 2019 | 246 | 4.140 |
Why?
|
| Subcutaneous Fat, Abdominal | 13 | 2015 | 91 | 3.700 |
Why?
|
| Glomerular Filtration Rate | 53 | 2017 | 2233 | 3.600 |
Why?
|
| Kidney Failure, Chronic | 29 | 2013 | 2504 | 3.350 |
Why?
|
| Obesity | 97 | 2018 | 13082 | 3.100 |
Why?
|
| Renal Insufficiency, Chronic | 32 | 2017 | 2307 | 3.000 |
Why?
|
| Polymorphism, Single Nucleotide | 115 | 2021 | 16039 | 2.460 |
Why?
|
| Calcinosis | 31 | 2018 | 1475 | 2.460 |
Why?
|
| Kidney Diseases | 24 | 2017 | 2100 | 2.450 |
Why?
|
| Genome-Wide Association Study | 105 | 2022 | 12803 | 2.400 |
Why?
|
| Obesity, Abdominal | 9 | 2015 | 370 | 2.100 |
Why?
|
| Body Mass Index | 99 | 2019 | 13042 | 2.090 |
Why?
|
| Abdominal Fat | 10 | 2016 | 217 | 2.040 |
Why?
|
| Genetic Loci | 27 | 2017 | 2630 | 1.670 |
Why?
|
| Middle Aged | 348 | 2019 | 223016 | 1.620 |
Why?
|
| Risk Factors | 191 | 2019 | 74850 | 1.600 |
Why?
|
| Kidney | 21 | 2017 | 7073 | 1.580 |
Why?
|
| Adipose Tissue | 23 | 2017 | 3314 | 1.570 |
Why?
|
| Genome, Human | 30 | 2017 | 4443 | 1.550 |
Why?
|
| Diabetes Mellitus, Type 2 | 63 | 2017 | 12235 | 1.470 |
Why?
|
| Aorta, Abdominal | 11 | 2017 | 626 | 1.430 |
Why?
|
| Male | 379 | 2021 | 363815 | 1.340 |
Why?
|
| Genetic Predisposition to Disease | 64 | 2019 | 18074 | 1.330 |
Why?
|
| Neck | 5 | 2016 | 735 | 1.310 |
Why?
|
| Genetic Linkage | 16 | 2011 | 2342 | 1.310 |
Why?
|
| Diabetes Mellitus | 30 | 2017 | 5889 | 1.300 |
Why?
|
| Female | 387 | 2021 | 396141 | 1.280 |
Why?
|
| Fatty Liver | 8 | 2017 | 810 | 1.280 |
Why?
|
| Waist Circumference | 26 | 2017 | 934 | 1.280 |
Why?
|
| Cystatin C | 11 | 2013 | 272 | 1.250 |
Why?
|
| Insulin Resistance | 36 | 2016 | 3988 | 1.210 |
Why?
|
| Aortic Diseases | 11 | 2017 | 741 | 1.200 |
Why?
|
| Aspartate Aminotransferases | 4 | 2016 | 416 | 1.200 |
Why?
|
| Cohort Studies | 116 | 2018 | 41680 | 1.180 |
Why?
|
| American Heart Association | 14 | 2015 | 1045 | 1.170 |
Why?
|
| Creatinine | 22 | 2016 | 1916 | 1.160 |
Why?
|
| Blood Glucose | 37 | 2016 | 6422 | 1.110 |
Why?
|
| Genetic Variation | 28 | 2019 | 6612 | 1.100 |
Why?
|
| Humans | 485 | 2022 | 765926 | 1.060 |
Why?
|
| Diabetic Angiopathies | 8 | 2014 | 805 | 1.030 |
Why?
|
| Adult | 226 | 2019 | 223088 | 1.020 |
Why?
|
| Diabetes Complications | 13 | 2013 | 1318 | 1.010 |
Why?
|
| Massachusetts | 50 | 2017 | 8882 | 0.990 |
Why?
|
| Incidence | 65 | 2018 | 21513 | 0.960 |
Why?
|
| Aged | 194 | 2018 | 171163 | 0.960 |
Why?
|
| Weight Gain | 10 | 2015 | 2356 | 0.950 |
Why?
|
| Uromodulin | 7 | 2014 | 49 | 0.910 |
Why?
|
| Hypertension | 32 | 2017 | 8616 | 0.900 |
Why?
|
| Heart Diseases | 13 | 2016 | 2818 | 0.880 |
Why?
|
| Pericardium | 12 | 2016 | 679 | 0.880 |
Why?
|
| Coronary Artery Disease | 23 | 2018 | 6544 | 0.880 |
Why?
|
| Periodicals as Topic | 4 | 2016 | 1463 | 0.870 |
Why?
|
| Alanine Transaminase | 3 | 2016 | 608 | 0.870 |
Why?
|
| Polymorphism, Genetic | 11 | 2016 | 4249 | 0.860 |
Why?
|
| Journal Impact Factor | 2 | 2015 | 157 | 0.860 |
Why?
|
| Cross-Sectional Studies | 57 | 2022 | 26282 | 0.850 |
Why?
|
| Uric Acid | 7 | 2014 | 809 | 0.840 |
Why?
|
| Multivariate Analysis | 34 | 2016 | 12059 | 0.830 |
Why?
|
| Aorta, Thoracic | 7 | 2018 | 1109 | 0.830 |
Why?
|
| Prediabetic State | 6 | 2016 | 547 | 0.800 |
Why?
|
| Odds Ratio | 30 | 2017 | 9656 | 0.800 |
Why?
|
| Phosphorus | 4 | 2011 | 336 | 0.780 |
Why?
|
| Fasting | 15 | 2016 | 1606 | 0.780 |
Why?
|
| Prevalence | 53 | 2018 | 15828 | 0.780 |
Why?
|
| Logistic Models | 34 | 2017 | 13273 | 0.770 |
Why?
|
| Linear Models | 23 | 2017 | 5873 | 0.760 |
Why?
|
| Sweetening Agents | 5 | 2016 | 291 | 0.750 |
Why?
|
| Kidney Function Tests | 12 | 2017 | 684 | 0.750 |
Why?
|
| Insulin | 27 | 2016 | 6603 | 0.730 |
Why?
|
| Coronary Disease | 18 | 2015 | 5919 | 0.730 |
Why?
|
| Risk Assessment | 44 | 2018 | 24275 | 0.720 |
Why?
|
| Ankle Brachial Index | 2 | 2012 | 164 | 0.710 |
Why?
|
| Waist-Hip Ratio | 15 | 2019 | 520 | 0.700 |
Why?
|
| Genotype | 46 | 2017 | 13026 | 0.680 |
Why?
|
| Longitudinal Studies | 35 | 2019 | 14745 | 0.680 |
Why?
|
| Tomography, X-Ray Computed | 48 | 2018 | 20690 | 0.670 |
Why?
|
| Mucoproteins | 2 | 2009 | 49 | 0.660 |
Why?
|
| Body Size | 7 | 2016 | 460 | 0.640 |
Why?
|
| Body Height | 13 | 2021 | 1561 | 0.630 |
Why?
|
| Genetic Markers | 10 | 2017 | 2603 | 0.630 |
Why?
|
| Adiponectin | 9 | 2016 | 1120 | 0.620 |
Why?
|
| Quantitative Trait Loci | 18 | 2017 | 2136 | 0.590 |
Why?
|
| Amino Acid Transport Systems, Basic | 2 | 2017 | 35 | 0.590 |
Why?
|
| Diabetic Nephropathies | 5 | 2015 | 968 | 0.590 |
Why?
|
| Phenotype | 43 | 2017 | 16714 | 0.590 |
Why?
|
| Beverages | 4 | 2016 | 819 | 0.580 |
Why?
|
| Gout | 6 | 2012 | 622 | 0.580 |
Why?
|
| Primary Prevention | 2 | 2015 | 1187 | 0.580 |
Why?
|
| Thyroid Gland | 3 | 2016 | 1168 | 0.580 |
Why?
|
| Blood Pressure | 26 | 2015 | 8530 | 0.570 |
Why?
|
| Receptors, Cell Surface | 5 | 2015 | 2814 | 0.570 |
Why?
|
| Adipokines | 2 | 2017 | 308 | 0.560 |
Why?
|
| Sex Factors | 26 | 2015 | 10611 | 0.560 |
Why?
|
| Follow-Up Studies | 57 | 2018 | 39228 | 0.560 |
Why?
|
| Resistin | 5 | 2012 | 174 | 0.560 |
Why?
|
| Motor Activity | 9 | 2016 | 2705 | 0.550 |
Why?
|
| Body Weight | 14 | 2015 | 4627 | 0.550 |
Why?
|
| Cause of Death | 8 | 2017 | 3715 | 0.550 |
Why?
|
| Proportional Hazards Models | 32 | 2017 | 12529 | 0.530 |
Why?
|
| Anthropometry | 9 | 2016 | 1339 | 0.520 |
Why?
|
| Proinsulin | 3 | 2011 | 135 | 0.510 |
Why?
|
| Iodide Peroxidase | 2 | 2008 | 295 | 0.500 |
Why?
|
| Overweight | 10 | 2014 | 2444 | 0.500 |
Why?
|
| Internet | 3 | 2016 | 3106 | 0.490 |
Why?
|
| Dyslipidemias | 7 | 2016 | 871 | 0.490 |
Why?
|
| Thyrotropin | 5 | 2016 | 834 | 0.490 |
Why?
|
| Coronary Vessels | 12 | 2018 | 3094 | 0.490 |
Why?
|
| Predictive Value of Tests | 24 | 2018 | 15401 | 0.480 |
Why?
|
| Gene Frequency | 20 | 2019 | 3623 | 0.470 |
Why?
|
| Population Surveillance | 4 | 2016 | 2596 | 0.460 |
Why?
|
| Atherosclerosis | 13 | 2018 | 3419 | 0.460 |
Why?
|
| Heart Valve Diseases | 4 | 2018 | 1029 | 0.460 |
Why?
|
| Electronic Mail | 1 | 2016 | 215 | 0.460 |
Why?
|
| Sex Characteristics | 11 | 2015 | 2645 | 0.460 |
Why?
|
| United States | 67 | 2018 | 72909 | 0.460 |
Why?
|
| Alleles | 16 | 2016 | 6891 | 0.450 |
Why?
|
| Cystatins | 3 | 2008 | 55 | 0.450 |
Why?
|
| Prospective Studies | 46 | 2018 | 54807 | 0.450 |
Why?
|
| Marketing | 1 | 2016 | 225 | 0.440 |
Why?
|
| Homocysteine | 2 | 2015 | 638 | 0.440 |
Why?
|
| Prolactin | 1 | 2016 | 625 | 0.440 |
Why?
|
| Sex Distribution | 11 | 2015 | 2269 | 0.430 |
Why?
|
| Renal Insufficiency | 3 | 2015 | 810 | 0.430 |
Why?
|
| Chromosome Mapping | 11 | 2015 | 4617 | 0.430 |
Why?
|
| Body Composition | 4 | 2012 | 2441 | 0.430 |
Why?
|
| Triglycerides | 12 | 2014 | 2440 | 0.420 |
Why?
|
| Models, Genetic | 8 | 2016 | 3447 | 0.410 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2013 | 489 | 0.410 |
Why?
|
| Severity of Illness Index | 18 | 2015 | 15878 | 0.410 |
Why?
|
| Myocardial Infarction | 10 | 2017 | 11508 | 0.400 |
Why?
|
| Vitamin K 1 | 1 | 2012 | 41 | 0.400 |
Why?
|
| Stroke | 16 | 2017 | 9739 | 0.400 |
Why?
|
| Neuropsychological Tests | 3 | 2016 | 7116 | 0.400 |
Why?
|
| Cholesterol, HDL | 15 | 2014 | 1813 | 0.400 |
Why?
|
| KCNQ1 Potassium Channel | 2 | 2011 | 103 | 0.390 |
Why?
|
| Bulimia | 1 | 2014 | 405 | 0.390 |
Why?
|
| Transaminases | 2 | 2012 | 199 | 0.390 |
Why?
|
| Renal Artery | 1 | 2013 | 355 | 0.390 |
Why?
|
| Vitamin B 12 | 1 | 2015 | 531 | 0.380 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2013 | 198 | 0.380 |
Why?
|
| Metabolic Diseases | 2 | 2016 | 686 | 0.380 |
Why?
|
| Hyperglycemia | 4 | 2008 | 1389 | 0.370 |
Why?
|
| Galectin 3 | 1 | 2013 | 238 | 0.370 |
Why?
|
| Amino Acids | 2 | 2017 | 1709 | 0.370 |
Why?
|
| Comorbidity | 18 | 2016 | 10575 | 0.370 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 586 | 0.370 |
Why?
|
| Epidemiologic Studies | 2 | 2016 | 677 | 0.370 |
Why?
|
| Tunica Intima | 6 | 2007 | 455 | 0.360 |
Why?
|
| Age Distribution | 11 | 2015 | 2864 | 0.360 |
Why?
|
| Actigraphy | 1 | 2015 | 526 | 0.360 |
Why?
|
| Proteins | 7 | 2019 | 5994 | 0.360 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2011 | 91 | 0.360 |
Why?
|
| Sarcopenia | 1 | 2016 | 378 | 0.360 |
Why?
|
| Diet | 9 | 2016 | 8087 | 0.350 |
Why?
|
| Diabetes Mellitus, Type 1 | 5 | 2014 | 3444 | 0.350 |
Why?
|
| Carotid Artery Diseases | 4 | 2006 | 872 | 0.350 |
Why?
|
| Angiopoietin-2 | 1 | 2011 | 186 | 0.350 |
Why?
|
| Adipocytes | 2 | 2016 | 1195 | 0.350 |
Why?
|
| Risk | 16 | 2015 | 9599 | 0.350 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2011 | 268 | 0.340 |
Why?
|
| Sodium | 4 | 2017 | 1591 | 0.340 |
Why?
|
| Zebrafish | 6 | 2016 | 3035 | 0.340 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2010 | 52 | 0.340 |
Why?
|
| Food Handling | 1 | 2010 | 158 | 0.340 |
Why?
|
| Chromosomes, Human | 4 | 2013 | 437 | 0.340 |
Why?
|
| Indians, North American | 5 | 2000 | 354 | 0.330 |
Why?
|
| Aged, 80 and over | 46 | 2017 | 59496 | 0.330 |
Why?
|
| Time Factors | 28 | 2017 | 40097 | 0.330 |
Why?
|
| Metabolome | 6 | 2016 | 1005 | 0.330 |
Why?
|
| Aldosterone | 5 | 2015 | 881 | 0.320 |
Why?
|
| Carbohydrates | 3 | 2016 | 387 | 0.320 |
Why?
|
| Receptors, Cannabinoid | 1 | 2009 | 43 | 0.320 |
Why?
|
| Angiography | 2 | 2015 | 1589 | 0.320 |
Why?
|
| Chromosomes, Human, 4-5 | 1 | 2008 | 26 | 0.320 |
Why?
|
| Prognosis | 24 | 2018 | 29890 | 0.320 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 2008 | 69 | 0.320 |
Why?
|
| Life Style | 11 | 2015 | 3928 | 0.310 |
Why?
|
| Hyperuricemia | 2 | 2009 | 222 | 0.310 |
Why?
|
| Troponin I | 1 | 2013 | 656 | 0.310 |
Why?
|
| Dementia | 2 | 2014 | 2741 | 0.310 |
Why?
|
| Cardiovascular System | 2 | 2013 | 838 | 0.310 |
Why?
|
| Sequence Analysis, DNA | 6 | 2014 | 4780 | 0.300 |
Why?
|
| Age Factors | 21 | 2016 | 18382 | 0.300 |
Why?
|
| Brachial Artery | 5 | 2013 | 374 | 0.300 |
Why?
|
| Reproduction | 1 | 2012 | 645 | 0.300 |
Why?
|
| Amidohydrolases | 1 | 2009 | 161 | 0.290 |
Why?
|
| Intermittent Claudication | 1 | 2010 | 305 | 0.290 |
Why?
|
| Case-Control Studies | 23 | 2019 | 22228 | 0.290 |
Why?
|
| Hospital Mortality | 3 | 2011 | 5339 | 0.290 |
Why?
|
| Organ Size | 8 | 2015 | 2261 | 0.290 |
Why?
|
| Carotid Artery, Common | 3 | 2006 | 172 | 0.280 |
Why?
|
| Peptides | 3 | 2014 | 4331 | 0.280 |
Why?
|
| Inflammation | 8 | 2014 | 10843 | 0.280 |
Why?
|
| Aortography | 5 | 2018 | 423 | 0.280 |
Why?
|
| Hypercholesterolemia | 4 | 2010 | 1148 | 0.280 |
Why?
|
| Reference Values | 11 | 2013 | 4909 | 0.280 |
Why?
|
| Lipids | 7 | 2019 | 3317 | 0.280 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2010 | 855 | 0.270 |
Why?
|
| Mitral Valve | 3 | 2016 | 1475 | 0.270 |
Why?
|
| Atrial Fibrillation | 8 | 2016 | 5186 | 0.270 |
Why?
|
| Decision Support Techniques | 2 | 2016 | 2004 | 0.270 |
Why?
|
| Tomography, Spiral Computed | 2 | 2007 | 273 | 0.270 |
Why?
|
| Infertility, Female | 1 | 2012 | 763 | 0.270 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2005 | 1568 | 0.260 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2013 | 2879 | 0.260 |
Why?
|
| Meta-Analysis as Topic | 14 | 2013 | 1366 | 0.260 |
Why?
|
| Registries | 4 | 2011 | 8346 | 0.260 |
Why?
|
| Calcium | 8 | 2017 | 5769 | 0.260 |
Why?
|
| Regression Analysis | 12 | 2014 | 6321 | 0.260 |
Why?
|
| Hyperlipidemias | 3 | 2015 | 770 | 0.260 |
Why?
|
| Wrist | 1 | 2007 | 230 | 0.250 |
Why?
|
| Patient Compliance | 1 | 2016 | 2693 | 0.250 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 1961 | 0.250 |
Why?
|
| Smoking | 13 | 2017 | 9082 | 0.250 |
Why?
|
| Endothelium, Vascular | 5 | 2015 | 4423 | 0.250 |
Why?
|
| Carotid Artery, Internal | 3 | 2006 | 440 | 0.250 |
Why?
|
| Abdomen | 3 | 2009 | 1135 | 0.250 |
Why?
|
| C-Reactive Protein | 12 | 2013 | 3851 | 0.250 |
Why?
|
| Quantitative Trait, Heritable | 5 | 2010 | 541 | 0.240 |
Why?
|
| Alanine | 1 | 2008 | 613 | 0.240 |
Why?
|
| Estrogen Receptor alpha | 2 | 2008 | 580 | 0.240 |
Why?
|
| Yogurt | 3 | 2015 | 71 | 0.240 |
Why?
|
| Muscle, Skeletal | 3 | 2017 | 4959 | 0.240 |
Why?
|
| Energy Intake | 8 | 2016 | 2141 | 0.240 |
Why?
|
| Genomics | 5 | 2015 | 5925 | 0.240 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 2 | 2011 | 1642 | 0.230 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2011 | 2136 | 0.230 |
Why?
|
| Acute Kidney Injury | 3 | 2017 | 1943 | 0.230 |
Why?
|
| Information Storage and Retrieval | 1 | 2010 | 831 | 0.230 |
Why?
|
| Radiography | 9 | 2015 | 6941 | 0.230 |
Why?
|
| Disease Progression | 14 | 2018 | 13614 | 0.230 |
Why?
|
| gamma-Glutamyltransferase | 3 | 2010 | 141 | 0.230 |
Why?
|
| Death Certificates | 1 | 2005 | 172 | 0.230 |
Why?
|
| Thoracic Cavity | 2 | 2016 | 11 | 0.230 |
Why?
|
| Liver | 9 | 2017 | 7559 | 0.220 |
Why?
|
| Parents | 5 | 2014 | 3591 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2006 | 370 | 0.220 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 1195 | 0.220 |
Why?
|
| Fetofetal Transfusion | 1 | 2005 | 119 | 0.220 |
Why?
|
| Aortic Valve | 4 | 2018 | 1964 | 0.220 |
Why?
|
| Weight Loss | 3 | 2013 | 2710 | 0.220 |
Why?
|
| Aorta | 2 | 2017 | 2040 | 0.220 |
Why?
|
| Gene Expression Regulation | 11 | 2017 | 11895 | 0.220 |
Why?
|
| Homeostasis | 8 | 2019 | 3338 | 0.210 |
Why?
|
| Carbonated Beverages | 3 | 2016 | 209 | 0.210 |
Why?
|
| Nutrition Surveys | 6 | 2015 | 1735 | 0.210 |
Why?
|
| Glucose Intolerance | 6 | 2010 | 578 | 0.210 |
Why?
|
| Carotid Arteries | 2 | 2009 | 932 | 0.210 |
Why?
|
| Metabolomics | 4 | 2017 | 1667 | 0.210 |
Why?
|
| Dietary Sucrose | 2 | 2015 | 241 | 0.210 |
Why?
|
| Lod Score | 5 | 2007 | 599 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 7423 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2004 | 432 | 0.200 |
Why?
|
| DNA | 3 | 2013 | 7193 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2017 | 3796 | 0.200 |
Why?
|
| Receptor, Melatonin, MT2 | 2 | 2015 | 84 | 0.190 |
Why?
|
| Cognition Disorders | 1 | 2016 | 3965 | 0.190 |
Why?
|
| Chronic Disease | 11 | 2011 | 9351 | 0.190 |
Why?
|
| Vitamin D | 3 | 2012 | 3272 | 0.190 |
Why?
|
| Mitral Valve Stenosis | 1 | 2004 | 342 | 0.190 |
Why?
|
| Evidence-Based Medicine | 2 | 2013 | 3690 | 0.190 |
Why?
|
| Renal Replacement Therapy | 1 | 2004 | 283 | 0.190 |
Why?
|
| Carrier Proteins | 2 | 2014 | 4909 | 0.190 |
Why?
|
| Confidence Intervals | 6 | 2012 | 2915 | 0.190 |
Why?
|
| Blood Coagulation Factors | 1 | 2004 | 372 | 0.190 |
Why?
|
| Cognition | 2 | 2016 | 7043 | 0.190 |
Why?
|
| Menopause | 4 | 2013 | 1659 | 0.190 |
Why?
|
| Haplotypes | 5 | 2010 | 2726 | 0.190 |
Why?
|
| Reproducibility of Results | 16 | 2017 | 20133 | 0.180 |
Why?
|
| Coronary Angiography | 10 | 2018 | 4498 | 0.180 |
Why?
|
| Thyroxine | 2 | 2016 | 665 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 4 | 2016 | 1601 | 0.180 |
Why?
|
| Models, Statistical | 5 | 2014 | 5088 | 0.180 |
Why?
|
| Dairy Products | 2 | 2015 | 490 | 0.180 |
Why?
|
| Health Surveys | 9 | 2013 | 4058 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 3498 | 0.180 |
Why?
|
| Genetic Research | 2 | 2013 | 173 | 0.180 |
Why?
|
| Observer Variation | 5 | 2014 | 2611 | 0.180 |
Why?
|
| Mississippi | 4 | 2015 | 93 | 0.180 |
Why?
|
| Forecasting | 3 | 2017 | 2936 | 0.180 |
Why?
|
| Research Report | 3 | 2014 | 367 | 0.170 |
Why?
|
| Aging | 8 | 2016 | 8725 | 0.170 |
Why?
|
| Genetic Association Studies | 5 | 2014 | 2744 | 0.170 |
Why?
|
| Europe | 7 | 2021 | 3430 | 0.170 |
Why?
|
| Algorithms | 7 | 2012 | 14064 | 0.170 |
Why?
|
| Sensitivity and Specificity | 11 | 2017 | 14643 | 0.170 |
Why?
|
| Natriuretic Peptides | 2 | 2011 | 153 | 0.170 |
Why?
|
| Feeding Behavior | 6 | 2015 | 3209 | 0.170 |
Why?
|
| Retrospective Studies | 24 | 2017 | 81537 | 0.170 |
Why?
|
| Molecular Motor Proteins | 2 | 2011 | 105 | 0.170 |
Why?
|
| Oxidative Stress | 3 | 2009 | 3140 | 0.170 |
Why?
|
| TCF Transcription Factors | 3 | 2010 | 137 | 0.170 |
Why?
|
| Chi-Square Distribution | 4 | 2017 | 3430 | 0.170 |
Why?
|
| Vasodilation | 3 | 2009 | 969 | 0.170 |
Why?
|
| Hypertriglyceridemia | 3 | 2014 | 292 | 0.160 |
Why?
|
| Leptin | 4 | 2016 | 1596 | 0.160 |
Why?
|
| Cytokines | 2 | 2012 | 7417 | 0.160 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2012 | 205 | 0.160 |
Why?
|
| Hyperlipoproteinemia Type II | 2 | 2015 | 396 | 0.160 |
Why?
|
| Apolipoprotein C-III | 2 | 2014 | 209 | 0.160 |
Why?
|
| Analysis of Variance | 6 | 2014 | 6202 | 0.160 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11639 | 0.160 |
Why?
|
| Air Pollutants | 3 | 2017 | 2922 | 0.160 |
Why?
|
| Glucose | 5 | 2017 | 4335 | 0.160 |
Why?
|
| Cardiology | 3 | 2015 | 1696 | 0.160 |
Why?
|
| Receptors, Calcium-Sensing | 2 | 2010 | 320 | 0.160 |
Why?
|
| Myosin Heavy Chains | 2 | 2011 | 403 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2012 | 797 | 0.150 |
Why?
|
| Probability | 6 | 2013 | 2474 | 0.150 |
Why?
|
| Erythrocytes | 3 | 2016 | 2394 | 0.150 |
Why?
|
| Family Health | 4 | 2017 | 1253 | 0.150 |
Why?
|
| Hypothyroidism | 2 | 2013 | 665 | 0.150 |
Why?
|
| Leukocyte Count | 2 | 2013 | 1605 | 0.150 |
Why?
|
| Gene Regulatory Networks | 3 | 2018 | 1748 | 0.150 |
Why?
|
| Games, Experimental | 1 | 2017 | 32 | 0.150 |
Why?
|
| Blood Proteins | 2 | 2014 | 1186 | 0.150 |
Why?
|
| Depression | 2 | 2018 | 8223 | 0.140 |
Why?
|
| Neoplasms | 4 | 2015 | 22340 | 0.140 |
Why?
|
| Basal Metabolism | 1 | 1998 | 163 | 0.140 |
Why?
|
| Exercise | 7 | 2022 | 5936 | 0.140 |
Why?
|
| omega-N-Methylarginine | 1 | 2017 | 108 | 0.140 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2017 | 30 | 0.140 |
Why?
|
| Young Adult | 20 | 2016 | 59857 | 0.140 |
Why?
|
| Body Weights and Measures | 2 | 2018 | 208 | 0.140 |
Why?
|
| Son of Sevenless Proteins | 1 | 2016 | 27 | 0.140 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2015 | 1735 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2017 | 36547 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2010 | 313 | 0.140 |
Why?
|
| Particulate Matter | 3 | 2017 | 2623 | 0.140 |
Why?
|
| Principal Component Analysis | 2 | 2017 | 947 | 0.140 |
Why?
|
| Linkage Disequilibrium | 8 | 2016 | 1996 | 0.140 |
Why?
|
| Mass Spectrometry | 4 | 2017 | 2194 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2014 | 2897 | 0.130 |
Why?
|
| Environmental Exposure | 3 | 2017 | 4544 | 0.130 |
Why?
|
| Apolipoprotein C-I | 1 | 2016 | 14 | 0.130 |
Why?
|
| Histidine | 1 | 2017 | 301 | 0.130 |
Why?
|
| Leukocytes | 2 | 2017 | 2027 | 0.130 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2016 | 39 | 0.130 |
Why?
|
| Animals | 26 | 2019 | 168735 | 0.130 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2017 | 110 | 0.130 |
Why?
|
| Vehicle Emissions | 2 | 2017 | 651 | 0.130 |
Why?
|
| Thorax | 2 | 2009 | 554 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 64 | 0.130 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.130 |
Why?
|
| Nutrition Assessment | 3 | 2014 | 738 | 0.120 |
Why?
|
| Kidney Medulla | 1 | 2015 | 169 | 0.120 |
Why?
|
| Thyroid Function Tests | 1 | 2016 | 289 | 0.120 |
Why?
|
| Iliac Artery | 1 | 2017 | 344 | 0.120 |
Why?
|
| Blood Pressure Determination | 2 | 2011 | 646 | 0.120 |
Why?
|
| Biotransformation | 1 | 2015 | 165 | 0.120 |
Why?
|
| Electrocardiography | 7 | 2014 | 6409 | 0.120 |
Why?
|
| Membrane Proteins | 8 | 2014 | 7847 | 0.120 |
Why?
|
| Urinalysis | 1 | 2017 | 369 | 0.120 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2014 | 63 | 0.120 |
Why?
|
| Hypolipidemic Agents | 3 | 2018 | 609 | 0.120 |
Why?
|
| Liver Function Tests | 1 | 2016 | 527 | 0.120 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 457 | 0.120 |
Why?
|
| Renin | 3 | 2015 | 647 | 0.120 |
Why?
|
| Organic Anion Transporters | 2 | 2014 | 101 | 0.120 |
Why?
|
| Receptors, Leptin | 1 | 2016 | 352 | 0.120 |
Why?
|
| Human Genome Project | 1 | 2015 | 202 | 0.120 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 249 | 0.120 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2014 | 58 | 0.110 |
Why?
|
| Environment | 2 | 2008 | 1119 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2010 | 8060 | 0.110 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2013 | 1225 | 0.110 |
Why?
|
| Heart | 6 | 2014 | 4419 | 0.110 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2016 | 291 | 0.110 |
Why?
|
| Hypertension, Renal | 1 | 2014 | 135 | 0.110 |
Why?
|
| Nephrolithiasis | 1 | 2015 | 117 | 0.110 |
Why?
|
| Survival Rate | 6 | 2013 | 12822 | 0.110 |
Why?
|
| Milk | 2 | 2015 | 436 | 0.110 |
Why?
|
| Health Priorities | 1 | 2017 | 382 | 0.110 |
Why?
|
| Choristoma | 1 | 2015 | 205 | 0.110 |
Why?
|
| Netherlands | 2 | 2009 | 2277 | 0.110 |
Why?
|
| Physical Chromosome Mapping | 1 | 2014 | 183 | 0.110 |
Why?
|
| Insurance Claim Reporting | 1 | 2014 | 166 | 0.110 |
Why?
|
| Atrial Function | 1 | 2014 | 98 | 0.110 |
Why?
|
| Alpha-Globulins | 1 | 2013 | 26 | 0.110 |
Why?
|
| Neurofibrillary Tangles | 1 | 2016 | 457 | 0.110 |
Why?
|
| Preventive Medicine | 1 | 2015 | 246 | 0.110 |
Why?
|
| Plasma | 1 | 2017 | 583 | 0.110 |
Why?
|
| Kidney Tubules | 1 | 2015 | 453 | 0.110 |
Why?
|
| Heart Function Tests | 2 | 2011 | 317 | 0.110 |
Why?
|
| 2-Aminoadipic Acid | 1 | 2013 | 32 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2017 | 1331 | 0.110 |
Why?
|
| Survival | 1 | 2014 | 160 | 0.110 |
Why?
|
| Intention to Treat Analysis | 1 | 2014 | 418 | 0.110 |
Why?
|
| Glycine | 1 | 2017 | 671 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2005 | 451 | 0.110 |
Why?
|
| Aftercare | 1 | 2019 | 915 | 0.110 |
Why?
|
| Alcohol Drinking | 4 | 2015 | 4041 | 0.110 |
Why?
|
| Tunica Media | 2 | 2004 | 107 | 0.110 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2010 | 45 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2013 | 533 | 0.110 |
Why?
|
| Lipodystrophy | 1 | 2014 | 145 | 0.110 |
Why?
|
| Mobility Limitation | 2 | 2016 | 409 | 0.110 |
Why?
|
| Diet, Fat-Restricted | 1 | 2015 | 328 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2013 | 76 | 0.100 |
Why?
|
| Erythropoiesis | 1 | 2016 | 691 | 0.100 |
Why?
|
| RNA-Binding Proteins | 3 | 2016 | 1882 | 0.100 |
Why?
|
| Walking | 2 | 2017 | 1198 | 0.100 |
Why?
|
| Mortality | 3 | 2017 | 2910 | 0.100 |
Why?
|
| Blood Flow Velocity | 4 | 2009 | 1377 | 0.100 |
Why?
|
| Patient Education as Topic | 3 | 2008 | 2331 | 0.100 |
Why?
|
| Radiography, Abdominal | 1 | 2015 | 543 | 0.100 |
Why?
|
| Health Status Indicators | 1 | 2018 | 967 | 0.100 |
Why?
|
| Lysine | 1 | 2017 | 993 | 0.100 |
Why?
|
| Lysophospholipase | 1 | 2012 | 65 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 3 | 2017 | 1529 | 0.100 |
Why?
|
| Heart Conduction System | 2 | 2016 | 1007 | 0.100 |
Why?
|
| State Medicine | 1 | 2014 | 219 | 0.100 |
Why?
|
| Glucose Tolerance Test | 6 | 2012 | 1180 | 0.100 |
Why?
|
| Adipose Tissue, White | 2 | 2018 | 371 | 0.100 |
Why?
|
| Lipoproteins, HDL | 3 | 2014 | 676 | 0.100 |
Why?
|
| Apolipoprotein E4 | 1 | 2016 | 707 | 0.100 |
Why?
|
| Caspase 9 | 1 | 2012 | 184 | 0.100 |
Why?
|
| ROC Curve | 4 | 2014 | 3612 | 0.100 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2017 | 1038 | 0.100 |
Why?
|
| Apolipoproteins B | 1 | 1993 | 385 | 0.090 |
Why?
|
| Cholesterol, LDL | 5 | 2015 | 2395 | 0.090 |
Why?
|
| Authorship | 1 | 2014 | 289 | 0.090 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2011 | 61 | 0.090 |
Why?
|
| Cardiovascular Agents | 2 | 2015 | 848 | 0.090 |
Why?
|
| Computational Biology | 4 | 2017 | 3562 | 0.090 |
Why?
|
| Feasibility Studies | 3 | 2015 | 5300 | 0.090 |
Why?
|
| Pulmonary Artery | 2 | 2011 | 1937 | 0.090 |
Why?
|
| Aortic Aneurysm | 2 | 2013 | 649 | 0.090 |
Why?
|
| Cell Count | 1 | 2015 | 1823 | 0.090 |
Why?
|
| Receptor, TIE-2 | 1 | 2011 | 183 | 0.090 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2011 | 91 | 0.090 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 3 | 2007 | 279 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 3 | 2013 | 899 | 0.090 |
Why?
|
| Muscles | 1 | 2015 | 1577 | 0.090 |
Why?
|
| Hyperthyroidism | 1 | 2013 | 292 | 0.090 |
Why?
|
| Mexico | 5 | 2000 | 771 | 0.090 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2012 | 489 | 0.090 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 11090 | 0.090 |
Why?
|
| Morbidity | 2 | 2008 | 1752 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2003 | 2068 | 0.090 |
Why?
|
| Pedigree | 4 | 2012 | 4535 | 0.090 |
Why?
|
| Genetics, Population | 3 | 2014 | 943 | 0.090 |
Why?
|
| Africa | 3 | 2021 | 725 | 0.090 |
Why?
|
| Homozygote | 1 | 2015 | 1774 | 0.090 |
Why?
|
| DNA Copy Number Variations | 3 | 2014 | 2045 | 0.090 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2010 | 44 | 0.090 |
Why?
|
| New England | 1 | 2013 | 1059 | 0.090 |
Why?
|
| Genetic Heterogeneity | 2 | 2010 | 735 | 0.090 |
Why?
|
| Survival Analysis | 5 | 2014 | 10086 | 0.090 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2011 | 138 | 0.090 |
Why?
|
| Systems Biology | 1 | 2014 | 481 | 0.090 |
Why?
|
| Random Allocation | 1 | 2014 | 2394 | 0.090 |
Why?
|
| Enzymes | 1 | 2011 | 253 | 0.080 |
Why?
|
| Parathyroid Hormone | 1 | 2016 | 1790 | 0.080 |
Why?
|
| Cadherins | 1 | 2014 | 899 | 0.080 |
Why?
|
| Heart Failure | 6 | 2017 | 11837 | 0.080 |
Why?
|
| Receptors, Virus | 1 | 2013 | 650 | 0.080 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2011 | 298 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 4 | 2012 | 4394 | 0.080 |
Why?
|
| Vitamin K | 1 | 2012 | 312 | 0.080 |
Why?
|
| Calcium, Dietary | 1 | 2012 | 527 | 0.080 |
Why?
|
| Mice | 11 | 2016 | 81782 | 0.080 |
Why?
|
| Triiodobenzoic Acids | 1 | 2009 | 124 | 0.080 |
Why?
|
| Inheritance Patterns | 2 | 2009 | 345 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 702 | 0.080 |
Why?
|
| Osteoprotegerin | 1 | 2010 | 178 | 0.080 |
Why?
|
| Gene Expression Profiling | 5 | 2018 | 9525 | 0.080 |
Why?
|
| Parity | 1 | 2012 | 931 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2011 | 558 | 0.080 |
Why?
|
| Receptors, Melatonin | 1 | 2008 | 31 | 0.080 |
Why?
|
| Adult Children | 2 | 2013 | 104 | 0.080 |
Why?
|
| Treatment Outcome | 12 | 2016 | 65194 | 0.080 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 663 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 2844 | 0.080 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 386 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2012 | 1159 | 0.080 |
Why?
|
| Publishing | 1 | 2016 | 836 | 0.080 |
Why?
|
| Self Report | 2 | 2018 | 3768 | 0.080 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 325 | 0.080 |
Why?
|
| Bayes Theorem | 2 | 2016 | 2353 | 0.080 |
Why?
|
| Interleukin-6 | 3 | 2011 | 3225 | 0.080 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2012 | 659 | 0.080 |
Why?
|
| RANK Ligand | 1 | 2010 | 320 | 0.080 |
Why?
|
| Databases, Genetic | 5 | 2014 | 1756 | 0.080 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 792 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 1893 | 0.080 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2011 | 658 | 0.080 |
Why?
|
| Early Diagnosis | 1 | 2013 | 1186 | 0.080 |
Why?
|
| Ultrasonography | 5 | 2006 | 5987 | 0.080 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2009 | 182 | 0.070 |
Why?
|
| Pulsatile Flow | 1 | 2009 | 318 | 0.070 |
Why?
|
| Guideline Adherence | 2 | 2016 | 2234 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2009 | 348 | 0.070 |
Why?
|
| Dietary Proteins | 1 | 2013 | 960 | 0.070 |
Why?
|
| Gait | 1 | 2013 | 819 | 0.070 |
Why?
|
| Cost of Illness | 2 | 2008 | 1949 | 0.070 |
Why?
|
| Aromatase | 1 | 2008 | 147 | 0.070 |
Why?
|
| Myocardium | 2 | 2011 | 4764 | 0.070 |
Why?
|
| Motivation | 1 | 2017 | 2018 | 0.070 |
Why?
|
| Pyrophosphatases | 1 | 2008 | 143 | 0.070 |
Why?
|
| Causality | 2 | 2011 | 1247 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 347 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2009 | 4342 | 0.070 |
Why?
|
| Epidemiology | 1 | 2010 | 278 | 0.070 |
Why?
|
| Glycemic Index | 1 | 2010 | 400 | 0.070 |
Why?
|
| Epididymis | 1 | 1989 | 227 | 0.070 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2008 | 238 | 0.070 |
Why?
|
| Ultrasonography, Doppler | 2 | 2006 | 462 | 0.070 |
Why?
|
| Estrogen Receptor beta | 1 | 2008 | 171 | 0.070 |
Why?
|
| Zinc | 1 | 2011 | 675 | 0.070 |
Why?
|
| Genetic Testing | 3 | 2017 | 3594 | 0.070 |
Why?
|
| Osmolar Concentration | 2 | 2017 | 655 | 0.070 |
Why?
|
| Magnesium | 1 | 2010 | 815 | 0.070 |
Why?
|
| Retroviridae | 1 | 1989 | 845 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2017 | 12129 | 0.070 |
Why?
|
| Models, Biological | 7 | 2015 | 9443 | 0.070 |
Why?
|
| DNA Helicases | 1 | 2012 | 852 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 3249 | 0.070 |
Why?
|
| Hyperemia | 1 | 2008 | 223 | 0.070 |
Why?
|
| Tomography | 1 | 2009 | 443 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2016 | 6503 | 0.070 |
Why?
|
| Disease Management | 1 | 2017 | 2530 | 0.070 |
Why?
|
| Heart Rate | 1 | 2018 | 4203 | 0.070 |
Why?
|
| Exons | 1 | 2012 | 2393 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2018 | 2190 | 0.060 |
Why?
|
| Social Support | 1 | 2016 | 2190 | 0.060 |
Why?
|
| Potassium | 1 | 2010 | 1312 | 0.060 |
Why?
|
| Adolescent | 14 | 2015 | 88811 | 0.060 |
Why?
|
| Ankle | 2 | 2006 | 353 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2009 | 4037 | 0.060 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2016 | 1563 | 0.060 |
Why?
|
| Fibrinogen | 1 | 2009 | 895 | 0.060 |
Why?
|
| Sclerosis | 1 | 2005 | 211 | 0.060 |
Why?
|
| Peripheral Arterial Disease | 1 | 2017 | 1308 | 0.060 |
Why?
|
| Femoral Artery | 1 | 2009 | 825 | 0.060 |
Why?
|
| Monte Carlo Method | 1 | 2010 | 1238 | 0.060 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 746 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2005 | 127 | 0.060 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 3 | 2010 | 152 | 0.060 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2011 | 1721 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 4520 | 0.060 |
Why?
|
| Fibroblast Growth Factors | 1 | 2010 | 871 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2005 | 361 | 0.060 |
Why?
|
| Antihypertensive Agents | 2 | 2018 | 2028 | 0.060 |
Why?
|
| Arteries | 3 | 2007 | 1120 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 10380 | 0.060 |
Why?
|
| Morphine | 1 | 2008 | 660 | 0.060 |
Why?
|
| Air Pollution | 1 | 2017 | 2380 | 0.060 |
Why?
|
| Age of Onset | 2 | 2008 | 3343 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2008 | 988 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 7599 | 0.050 |
Why?
|
| Apolipoproteins | 1 | 2006 | 327 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2823 | 0.050 |
Why?
|
| Informed Consent | 1 | 2010 | 1010 | 0.050 |
Why?
|
| Epidemiologic Research Design | 1 | 2007 | 368 | 0.050 |
Why?
|
| Chemokine CCL2 | 1 | 2006 | 602 | 0.050 |
Why?
|
| Aortic Valve Stenosis | 1 | 2016 | 2022 | 0.050 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 539 | 0.050 |
Why?
|
| Diuretics | 1 | 2006 | 611 | 0.050 |
Why?
|
| Apolipoproteins E | 2 | 2011 | 1459 | 0.050 |
Why?
|
| Outpatients | 1 | 2011 | 1595 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 1884 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2009 | 1319 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2013 | 2555 | 0.050 |
Why?
|
| Immune Tolerance | 1 | 2012 | 2324 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2009 | 1531 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2017 | 5595 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 22327 | 0.050 |
Why?
|
| Arteriosclerosis | 2 | 2004 | 1055 | 0.050 |
Why?
|
| Hemorrhage | 2 | 2011 | 3466 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2005 | 640 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 3690 | 0.050 |
Why?
|
| Child, Preschool | 8 | 2015 | 42510 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2017 | 4424 | 0.050 |
Why?
|
| Kidney Glomerulus | 1 | 2005 | 567 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 798 | 0.050 |
Why?
|
| Molecular Sequence Annotation | 2 | 2015 | 525 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 1132 | 0.050 |
Why?
|
| Adipogenesis | 2 | 2015 | 370 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2011 | 2444 | 0.050 |
Why?
|
| Mental Recall | 1 | 2008 | 1217 | 0.050 |
Why?
|
| Lung Volume Measurements | 2 | 2015 | 381 | 0.050 |
Why?
|
| Social Class | 1 | 2011 | 2007 | 0.050 |
Why?
|
| Heart Ventricles | 3 | 2010 | 3833 | 0.050 |
Why?
|
| Brain | 3 | 2016 | 27179 | 0.050 |
Why?
|
| Carotid Stenosis | 2 | 2006 | 857 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2008 | 1415 | 0.050 |
Why?
|
| Actinin | 1 | 2022 | 165 | 0.050 |
Why?
|
| Mutation, Missense | 4 | 2013 | 2589 | 0.050 |
Why?
|
| Vaginitis | 1 | 2001 | 50 | 0.050 |
Why?
|
| Stem Cells | 2 | 2013 | 3537 | 0.050 |
Why?
|
| Testosterone | 2 | 2011 | 2495 | 0.050 |
Why?
|
| Smoking Cessation | 1 | 2013 | 2084 | 0.050 |
Why?
|
| Child | 12 | 2015 | 80568 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2019 | 8724 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2013 | 2901 | 0.050 |
Why?
|
| Health Policy | 1 | 2013 | 2699 | 0.050 |
Why?
|
| Patient Selection | 3 | 2009 | 4248 | 0.050 |
Why?
|
| Neoplasms, Second Primary | 1 | 2009 | 1056 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2009 | 1363 | 0.040 |
Why?
|
| Family | 3 | 2010 | 3208 | 0.040 |
Why?
|
| Chromatography, Liquid | 2 | 2016 | 991 | 0.040 |
Why?
|
| Estradiol | 1 | 2008 | 1947 | 0.040 |
Why?
|
| Leisure Activities | 1 | 2022 | 310 | 0.040 |
Why?
|
| HIV-1 | 4 | 2001 | 6945 | 0.040 |
Why?
|
| Environmental Monitoring | 2 | 2017 | 1467 | 0.040 |
Why?
|
| Insulin, Long-Acting | 1 | 2000 | 59 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2008 | 2740 | 0.040 |
Why?
|
| Lung | 2 | 2010 | 10046 | 0.040 |
Why?
|
| Proteomics | 1 | 2014 | 3906 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2009 | 1348 | 0.040 |
Why?
|
| Echocardiography, Doppler | 1 | 2004 | 899 | 0.040 |
Why?
|
| Inpatients | 1 | 2011 | 2563 | 0.040 |
Why?
|
| Mycobacterium avium | 1 | 1999 | 30 | 0.040 |
Why?
|
| Cholesterol | 1 | 2009 | 2902 | 0.040 |
Why?
|
| Software | 1 | 2014 | 4462 | 0.040 |
Why?
|
| Mutation | 3 | 2014 | 30192 | 0.040 |
Why?
|
| RNA, Viral | 3 | 2001 | 2866 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 3592 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 2004 | 968 | 0.040 |
Why?
|
| Celiac Disease | 1 | 2007 | 820 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 4782 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 1 | 1999 | 283 | 0.040 |
Why?
|
| Acute Coronary Syndrome | 1 | 2011 | 2185 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 1 | 2004 | 871 | 0.040 |
Why?
|
| Hospitalization | 2 | 2010 | 10810 | 0.040 |
Why?
|
| Calorimetry, Indirect | 1 | 1998 | 176 | 0.040 |
Why?
|
| Nitrogen Oxides | 1 | 2017 | 128 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2012 | 9600 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2007 | 1791 | 0.040 |
Why?
|
| Pregnancy | 2 | 2012 | 30230 | 0.040 |
Why?
|
| Virus Activation | 1 | 1999 | 322 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2010 | 3930 | 0.030 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 3816 | 0.030 |
Why?
|
| Hypoglycemic Agents | 4 | 2018 | 3106 | 0.030 |
Why?
|
| Sulfates | 1 | 2017 | 375 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2010 | 3460 | 0.030 |
Why?
|
| Patient Admission | 1 | 2004 | 1365 | 0.030 |
Why?
|
| Energy Metabolism | 2 | 2015 | 2894 | 0.030 |
Why?
|
| Cathepsin C | 1 | 2015 | 4 | 0.030 |
Why?
|
| Soot | 1 | 2017 | 219 | 0.030 |
Why?
|
| Disease Susceptibility | 3 | 2007 | 1787 | 0.030 |
Why?
|
| Medicare | 1 | 2014 | 6815 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2016 | 163 | 0.030 |
Why?
|
| Heart Valves | 1 | 2017 | 284 | 0.030 |
Why?
|
| Mass Screening | 2 | 2007 | 5449 | 0.030 |
Why?
|
| Monosaccharides | 1 | 2015 | 64 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2014 | 23597 | 0.030 |
Why?
|
| Vagina | 1 | 2001 | 849 | 0.030 |
Why?
|
| Educational Status | 2 | 2015 | 2510 | 0.030 |
Why?
|
| Gene Expression | 3 | 2014 | 7581 | 0.030 |
Why?
|
| LDL-Receptor Related Protein-Associated Protein | 1 | 2014 | 17 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2016 | 355 | 0.030 |
Why?
|
| Nuclear Family | 2 | 2007 | 311 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3788 | 0.030 |
Why?
|
| Sulfotransferases | 1 | 2015 | 151 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 353 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 8722 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 2014 | 2717 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2012 | 1769 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 2 | 2009 | 873 | 0.030 |
Why?
|
| Monitoring, Ambulatory | 1 | 2017 | 357 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2015 | 246 | 0.030 |
Why?
|
| Ozone | 1 | 2017 | 499 | 0.030 |
Why?
|
| Cell Line | 4 | 2013 | 15540 | 0.030 |
Why?
|
| Independent Living | 1 | 2018 | 583 | 0.030 |
Why?
|
| Spouses | 1 | 2016 | 286 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2013 | 1964 | 0.030 |
Why?
|
| Socioeconomic Factors | 3 | 2013 | 7842 | 0.030 |
Why?
|
| Sepsis | 1 | 2007 | 2603 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 856 | 0.030 |
Why?
|
| Inhibin-beta Subunits | 1 | 2012 | 27 | 0.030 |
Why?
|
| Integrin alpha4 | 1 | 2013 | 89 | 0.030 |
Why?
|
| Housing | 1 | 2017 | 683 | 0.030 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2013 | 78 | 0.030 |
Why?
|
| Apolipoprotein B-100 | 1 | 1993 | 157 | 0.030 |
Why?
|
| Purinergic Antagonists | 1 | 1992 | 10 | 0.030 |
Why?
|
| Lipoproteins, LDL | 2 | 2014 | 643 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 798 | 0.030 |
Why?
|
| GATA2 Transcription Factor | 1 | 2013 | 158 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 286 | 0.030 |
Why?
|
| Body Surface Area | 1 | 2013 | 206 | 0.020 |
Why?
|
| Goals | 1 | 2017 | 717 | 0.020 |
Why?
|
| Xanthines | 1 | 1992 | 121 | 0.020 |
Why?
|
| Inhibins | 1 | 2012 | 210 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2013 | 212 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2017 | 811 | 0.020 |
Why?
|
| Physical Exertion | 1 | 1995 | 666 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2008 | 3834 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2012 | 189 | 0.020 |
Why?
|
| Diet Records | 1 | 2013 | 425 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Pakistan | 1 | 2012 | 300 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 1997 | 818 | 0.020 |
Why?
|
| Neurocan | 1 | 2011 | 21 | 0.020 |
Why?
|
| Drosophila | 1 | 2019 | 1505 | 0.020 |
Why?
|
| Interferon Regulatory Factors | 1 | 2013 | 271 | 0.020 |
Why?
|
| Epigenomics | 1 | 2017 | 958 | 0.020 |
Why?
|
| Genetic Drift | 1 | 2011 | 41 | 0.020 |
Why?
|
| Epithelium | 2 | 2001 | 1603 | 0.020 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 386 | 0.020 |
Why?
|
| Amino Acids, Aromatic | 1 | 2011 | 36 | 0.020 |
Why?
|
| Social Mobility | 1 | 2011 | 30 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2016 | 12768 | 0.020 |
Why?
|
| Interleukin-11 | 1 | 2010 | 58 | 0.020 |
Why?
|
| Locomotion | 1 | 2013 | 384 | 0.020 |
Why?
|
| San Francisco | 1 | 2011 | 165 | 0.020 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2011 | 142 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
| North America | 1 | 2014 | 1287 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2010 | 165 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.020 |
Why?
|
| Proteinuria | 1 | 2013 | 606 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 1828 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2004 | 3230 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 116 | 0.020 |
Why?
|
| Asia | 1 | 2011 | 630 | 0.020 |
Why?
|
| Finland | 1 | 2011 | 608 | 0.020 |
Why?
|
| Boston | 2 | 2015 | 9334 | 0.020 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2011 | 223 | 0.020 |
Why?
|
| Fatty Acid Desaturases | 1 | 2010 | 102 | 0.020 |
Why?
|
| Fiducial Markers | 1 | 2011 | 134 | 0.020 |
Why?
|
| Receptors, Chemokine | 1 | 2013 | 651 | 0.020 |
Why?
|
| Micronutrients | 1 | 2012 | 390 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2014 | 1637 | 0.020 |
Why?
|
| Arizona | 2 | 2000 | 108 | 0.020 |
Why?
|
| Nucleotides | 1 | 2012 | 453 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2010 | 322 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2015 | 1075 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2015 | 1119 | 0.020 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2010 | 108 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2010 | 175 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 2011 | 2688 | 0.020 |
Why?
|
| Chlorides | 1 | 1992 | 666 | 0.020 |
Why?
|
| Albumins | 1 | 2012 | 578 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2015 | 1349 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 5836 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2012 | 673 | 0.020 |
Why?
|
| Ribosomes | 1 | 2012 | 494 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2013 | 549 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2017 | 1062 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2015 | 1181 | 0.020 |
Why?
|
| California | 1 | 1993 | 1435 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2011 | 472 | 0.020 |
Why?
|
| Glutamine | 1 | 2012 | 574 | 0.020 |
Why?
|
| Incretins | 1 | 2010 | 100 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2010 | 507 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 514 | 0.020 |
Why?
|
| Lipase | 1 | 2011 | 320 | 0.020 |
Why?
|
| Ireland | 1 | 2009 | 171 | 0.020 |
Why?
|
| Biological Transport | 1 | 2013 | 2081 | 0.020 |
Why?
|
| CHO Cells | 1 | 2011 | 1372 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2016 | 1820 | 0.020 |
Why?
|
| Meperidine | 1 | 2008 | 37 | 0.020 |
Why?
|
| Sufentanil | 1 | 2008 | 42 | 0.020 |
Why?
|
| Genes | 1 | 2012 | 1824 | 0.020 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2011 | 266 | 0.020 |
Why?
|
| Ornithine | 1 | 2008 | 79 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2011 | 402 | 0.020 |
Why?
|
| Occupations | 1 | 2011 | 516 | 0.020 |
Why?
|
| Rats | 2 | 2015 | 23708 | 0.020 |
Why?
|
| Cohort Effect | 1 | 2008 | 39 | 0.020 |
Why?
|
| Diphenhydramine | 1 | 2008 | 61 | 0.020 |
Why?
|
| Echocardiography | 2 | 2011 | 5040 | 0.020 |
Why?
|
| Sample Size | 1 | 2011 | 843 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 1081 | 0.020 |
Why?
|
| HIV Core Protein p24 | 2 | 1999 | 245 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2016 | 1161 | 0.020 |
Why?
|
| Lymph Nodes | 2 | 1996 | 3447 | 0.020 |
Why?
|
| Immunoassay | 1 | 2011 | 742 | 0.020 |
Why?
|
| HIV Infections | 4 | 2001 | 17531 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 1305 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 5379 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1370 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 2412 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2011 | 592 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 2011 | 795 | 0.020 |
Why?
|
| Glyburide | 1 | 2008 | 117 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2017 | 2116 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2001 | 2586 | 0.020 |
Why?
|
| Morus | 1 | 2007 | 2 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 774 | 0.020 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2009 | 325 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2010 | 838 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 2796 | 0.020 |
Why?
|
| Biopsy | 2 | 2016 | 6766 | 0.020 |
Why?
|
| Adenosine | 1 | 1992 | 813 | 0.020 |
Why?
|
| Cytophotometry | 1 | 1987 | 8 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2011 | 779 | 0.020 |
Why?
|
| Northern Ireland | 1 | 2007 | 37 | 0.020 |
Why?
|
| Erythrocyte Count | 1 | 2007 | 157 | 0.020 |
Why?
|
| Dinoprost | 1 | 2007 | 139 | 0.020 |
Why?
|
| Sunlight | 1 | 2009 | 335 | 0.020 |
Why?
|
| Ethanol | 1 | 2013 | 1325 | 0.020 |
Why?
|
| Physicians | 1 | 2005 | 4591 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 5999 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2013 | 2350 | 0.020 |
Why?
|
| Sucrose | 1 | 2007 | 155 | 0.020 |
Why?
|
| Systole | 1 | 2009 | 935 | 0.020 |
Why?
|
| Cats | 1 | 2008 | 972 | 0.020 |
Why?
|
| Population Groups | 1 | 2008 | 209 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 1725 | 0.020 |
Why?
|
| Diastole | 1 | 2009 | 785 | 0.020 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2007 | 85 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 1880 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2009 | 784 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2006 | 152 | 0.020 |
Why?
|
| Hypoglycemia | 2 | 2006 | 896 | 0.020 |
Why?
|
| Blood Circulation | 1 | 2007 | 248 | 0.020 |
Why?
|
| Tuberculosis | 1 | 1999 | 2009 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2008 | 5784 | 0.020 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1992 | 1206 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2013 | 1247 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1989 | 1643 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1989 | 2543 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2006 | 4851 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 1213 | 0.020 |
Why?
|
| Apolipoproteins A | 1 | 2006 | 94 | 0.020 |
Why?
|
| Radiation Pneumonitis | 1 | 2006 | 98 | 0.020 |
Why?
|
| Lipoprotein Lipase | 1 | 2006 | 133 | 0.020 |
Why?
|
| Naloxone | 1 | 2008 | 373 | 0.020 |
Why?
|
| Synapses | 1 | 2015 | 1758 | 0.020 |
Why?
|
| Pulmonary Circulation | 1 | 2008 | 744 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 2089 | 0.020 |
Why?
|
| Cell Size | 1 | 2007 | 626 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10727 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2006 | 275 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2007 | 13446 | 0.020 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2006 | 113 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1989 | 503 | 0.010 |
Why?
|
| Phytotherapy | 1 | 2007 | 296 | 0.010 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2011 | 781 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2013 | 1304 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 412 | 0.010 |
Why?
|
| Fentanyl | 1 | 2008 | 451 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 1527 | 0.010 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 1194 | 0.010 |
Why?
|
| Nursing Diagnosis | 1 | 2004 | 16 | 0.010 |
Why?
|
| Glutens | 1 | 2007 | 240 | 0.010 |
Why?
|
| HIV | 1 | 1991 | 1587 | 0.010 |
Why?
|
| Androgens | 1 | 2011 | 1278 | 0.010 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2005 | 167 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 1670 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 1740 | 0.010 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 1093 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2008 | 1416 | 0.010 |
Why?
|
| Diet, Reducing | 1 | 2007 | 487 | 0.010 |
Why?
|
| Injections | 1 | 2006 | 839 | 0.010 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2009 | 565 | 0.010 |
Why?
|
| Monocytes | 1 | 2013 | 2591 | 0.010 |
Why?
|
| Plant Extracts | 1 | 2007 | 493 | 0.010 |
Why?
|
| Hemostasis | 1 | 2006 | 467 | 0.010 |
Why?
|
| Exercise Test | 1 | 2011 | 2185 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 1992 | 1284 | 0.010 |
Why?
|
| Caffeine | 1 | 2007 | 702 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2011 | 8924 | 0.010 |
Why?
|
| England | 1 | 2004 | 533 | 0.010 |
Why?
|
| Viremia | 2 | 1996 | 727 | 0.010 |
Why?
|
| Placebos | 1 | 2007 | 1659 | 0.010 |
Why?
|
| Patient Preference | 1 | 2010 | 947 | 0.010 |
Why?
|
| Base Sequence | 1 | 1993 | 12405 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2008 | 979 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2009 | 4044 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2014 | 3953 | 0.010 |
Why?
|
| Multifactorial Inheritance | 1 | 2010 | 1426 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 3606 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2006 | 681 | 0.010 |
Why?
|
| Fibrinolytic Agents | 1 | 2011 | 2076 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 1894 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2012 | 2969 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2009 | 2601 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 4130 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 8037 | 0.010 |
Why?
|
| Minority Groups | 1 | 2008 | 1208 | 0.010 |
Why?
|
| Patient Participation | 1 | 2010 | 1447 | 0.010 |
Why?
|
| Fertility | 1 | 2005 | 770 | 0.010 |
Why?
|
| Dyspnea | 1 | 1989 | 1351 | 0.010 |
Why?
|
| Physical Examination | 1 | 2007 | 1263 | 0.010 |
Why?
|
| Langerhans Cells | 1 | 2001 | 169 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2016 | 14450 | 0.010 |
Why?
|
| Thailand | 1 | 2001 | 288 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1993 | 17596 | 0.010 |
Why?
|
| Bone Density | 1 | 2013 | 3491 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 2430 | 0.010 |
Why?
|
| Cisplatin | 1 | 2006 | 1654 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1989 | 2204 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 2795 | 0.010 |
Why?
|
| Toxoplasmosis, Animal | 1 | 1999 | 19 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2012 | 3427 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2006 | 2863 | 0.010 |
Why?
|
| Piperidines | 1 | 2008 | 1664 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2008 | 2020 | 0.010 |
Why?
|
| Recurrence | 1 | 2011 | 8492 | 0.010 |
Why?
|
| Food Hypersensitivity | 1 | 2007 | 734 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2014 | 3458 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2011 | 5126 | 0.010 |
Why?
|
| Gene Products, gag | 1 | 1999 | 317 | 0.010 |
Why?
|
| Self Care | 1 | 2004 | 800 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2011 | 11196 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2009 | 4186 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2008 | 1979 | 0.010 |
Why?
|
| Infant | 3 | 2008 | 36426 | 0.010 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 1978 | 33 | 0.010 |
Why?
|
| Toxoplasma | 1 | 1999 | 158 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1987 | 2864 | 0.010 |
Why?
|
| Virus Replication | 2 | 1999 | 2450 | 0.010 |
Why?
|
| Research Design | 1 | 2014 | 6204 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2011 | 6251 | 0.010 |
Why?
|
| Northwestern United States | 1 | 1997 | 20 | 0.010 |
Why?
|
| Alaska | 1 | 1997 | 68 | 0.010 |
Why?
|
| Virion | 1 | 1999 | 428 | 0.010 |
Why?
|
| Seat Belts | 1 | 1997 | 60 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18292 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2009 | 3586 | 0.010 |
Why?
|
| HIV Seropositivity | 2 | 1995 | 961 | 0.010 |
Why?
|
| Didanosine | 1 | 1996 | 151 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2011 | 4856 | 0.010 |
Why?
|
| Nevirapine | 1 | 1996 | 273 | 0.010 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2001 | 668 | 0.010 |
Why?
|
| Cholestasis | 1 | 1978 | 385 | 0.010 |
Why?
|
| Zidovudine | 1 | 1996 | 626 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 8522 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2000 | 2108 | 0.010 |
Why?
|
| Communication | 1 | 2008 | 3908 | 0.010 |
Why?
|
| Cineangiography | 1 | 1973 | 108 | 0.010 |
Why?
|
| Spleen | 1 | 1999 | 2294 | 0.010 |
Why?
|
| Lipoproteins | 1 | 1978 | 870 | 0.010 |
Why?
|
| 2-Chloroadenosine | 1 | 1992 | 11 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 1885 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1987 | 2924 | 0.010 |
Why?
|
| Viral Load | 1 | 2001 | 3385 | 0.010 |
Why?
|
| Progestins | 1 | 1992 | 300 | 0.010 |
Why?
|
| Melanoma | 1 | 2009 | 5695 | 0.010 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1991 | 379 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1996 | 2196 | 0.010 |
Why?
|
| Autopsy | 1 | 1973 | 1011 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2004 | 4055 | 0.010 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 1992 | 452 | 0.000 |
Why?
|
| Circadian Rhythm | 1 | 2000 | 2594 | 0.000 |
Why?
|
| Colorectal Neoplasms | 1 | 2009 | 6958 | 0.000 |
Why?
|
| Perfusion | 1 | 1973 | 1408 | 0.000 |
Why?
|
| Catheterization | 1 | 1973 | 1426 | 0.000 |
Why?
|
| Estrogens | 1 | 1995 | 1528 | 0.000 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1995 | 1852 | 0.000 |
Why?
|
| HIV Antibodies | 1 | 1995 | 1337 | 0.000 |
Why?
|
| Chromosome Deletion | 1 | 1992 | 1384 | 0.000 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1989 | 241 | 0.000 |
Why?
|
| Heart Block | 1 | 1949 | 391 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1999 | 9541 | 0.000 |
Why?
|
| Urban Population | 1 | 1995 | 2040 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2007 | 26380 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1996 | 6306 | 0.000 |
Why?
|
| Ploidies | 1 | 1987 | 287 | 0.000 |
Why?
|
| Ventricular Fibrillation | 1 | 1949 | 538 | 0.000 |
Why?
|
| Cerebrovascular Disorders | 1 | 1992 | 1475 | 0.000 |
Why?
|
| Kinetics | 1 | 1992 | 6273 | 0.000 |
Why?
|
| Pyridines | 1 | 1996 | 2885 | 0.000 |
Why?
|
| Macrophages | 1 | 1999 | 5772 | 0.000 |
Why?
|
| Hip Fractures | 1 | 1992 | 995 | 0.000 |
Why?
|
| Breast Neoplasms | 2 | 2007 | 21069 | 0.000 |
Why?
|
| Antiviral Agents | 1 | 1996 | 3053 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1999 | 18962 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 13631 | 0.000 |
Why?
|
| Endometrial Neoplasms | 1 | 1992 | 1378 | 0.000 |
Why?
|
| Poverty | 1 | 1995 | 2714 | 0.000 |
Why?
|
| DNA, Neoplasm | 1 | 1987 | 1739 | 0.000 |
Why?
|
| Colonic Neoplasms | 1 | 1992 | 2530 | 0.000 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1949 | 2255 | 0.000 |
Why?
|
| Lipoproteins, VLDL | 1 | 1978 | 198 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1992 | 6360 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 1992 | 5450 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1991 | 9239 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1989 | 12973 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1987 | 11858 | 0.000 |
Why?
|